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Abstract
This review is addressed two pathophysiologic mechanisms implicated in the pathogenesis of nasal polyposis: the
unique remodeling process found in nasal polyp tissue and the immune response of patients with nasal polyposis
to Staphylococcus aureus.
These two theories converge to the same direction in different aspects, including decreased extracellular matrix
production, impaired T regulation and favoring of a Th2 immune response.
In patients with nasal polyposis, an exaggerated immune response to Staphylococcus aureus may aggravate the
airway remodeling process.
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In this article, we will discuss two important mechanisms
implicated in the pathophysiology of nasal polyposis that
have recently received much research attention, and high-
light aspects in which these mechanisms intersect.
This review clearly shows the potential for exacerbation
of the nasal polyp remodelling process due to an immune
response to Staphylococcus aureus.
Characteristics of the airway remodelling process
in chronic rhinosinusitis with nasal polyps
(CRSwNP)
Many authors consider the lower and upper airways as a
continuum [1] of tissue that shares the same pseudostrati-
fied ciliated columnar epithelium lining. Furthermore, the
“one airway, one disease” concept is widely known and
established the world over. Asthma and nasal polyposis
essentially share the same inflammatory characteristics: a
predominance of eosinophil infiltration, goblet cell hyper-
plasia, and a Th2-cell immune response [2,3]. The simi-
larities between the upper and lower airway mucosa and
the inflammatory processes that affect them, associated
with the fact that polyposis in the lung mucosa is virtually
unheard of, make the bronchial mucosa an extraordinary
model for the study of nasal polyposis [4].
There are some important differences in the remodeling
process between the lower and upper airway: nasal epithe-
lial disruption, basement membrane pseudothickening,
and elastase-positive cells, which are less numerous in the
nasal mucosa than in lung mucosa [5]. Nasal polyposis
also features major edema, albumin-filled pseudocysts,
and alpha-2-macroglobulin; in CRSwNP, soft tissue edema
and overgrowth of nasal mucosa predominate [6]. Con-
versely, in chronic rhinosinusitis without nasal polyps
(CRSsNP), there is mucosal fibrosis with an increase in
collagen.
The importance of the epithelium is demonstrated
experimentally when injured epithelium results in
impaired repair and an increase in the production and
release of TGF-ß [7].
TGF-ß1 is a cytokine produced by most immune cells,
fibroblasts and many other cells; it is considered a pleio-
tropic and multifunctional growth factor with important
immunomodulatory and fibrogenic effects.
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The function of TGF-ß1, however, does not seem to be
one-dimensional. A dual anti-inflammatory and profibrotic
role may occur [8].
The role of TGF-ß1 expression in nasal polyposis is
still controversial. Some authors advocate that TGF-ß1
is increased in nasal polyposis compared to healthy nasal
mucosa or CRSsNP, but these studies used immunohis-
tochemistry to support their findings [9,10], while others
have reported opposite findings with use of quantitative
methods such as Elisa or PCR in nasal tissue homoge-
nates [2,11].
It is also important to consider the fact that, in nasal
polyposis, TGF-ß1 expression patterns are different in the
stroma and epithelium, being higher and lower respectively
as compared with control nasal mucosa.
TGF-ß1 plays an important role in the balance of
fibrinolysis and fibrogenesis and, consequently, on the
extracellular matrix (ECM).
In NP tissue, matrix metalloproteinase 7 (MMP-7) and
matrix metalloproteinase 9 (MMP-9) levels are increased
and tissue inhibitor of metalloproteinases 1 (TIMP-1)
levels are decreased as compared with normal nasal
mucosa [12].
This imbalance can be partially explained by the lack
of TGF-ß1 in NP and its inhibitory effect on MMP-9
activity via TIMP-1 release [13].
For the same reason, in NP, TGF-ß1-activated PAI-1
(plasminogen activator inhibitor-1) is decreased and,
consequently, plasminogen activator and MMP levels
are increased as compared with controls and patients
with CRSsNP [14].
The hypothesis that CRSsNP is characterized by fibrosis,
high levels of TGF-ß and increased Treg activity, whereas
NP is characterized by edema, a lack of extracellular
matrix, and low TGF-ß levels and Treg activity [4,6] is the
cornerstone of the chronic rhinosinusitis remodelling
process, according to recent studies.
Impact of Staphylococcus aureus superantigens on
chronic rhinosinusitis with nasal polyps
NP is a severe chronic inflammatory disease involving the
paranasal sinuses that is frequently associated with asthma
and aspirin sensitivity. NP in combination with aspirin-
induced asthma (AIA) represents the most severe form of
airway inflammation within the group of patients with
NP. The pathophysiology of NP is not fully understood,
and is most likely to be multifactorial. Over the years, this
disease has frequently been linked to staphylococcal
colonization and, particularly, to bacterial products such
as enterotoxins from Staphylococcus aureus.
Staphylococcal species are the most prevalent bacteria
that have been isolated from the nasal mucus of white pa-
tients with NP. An increased colonization rate of S. aureus
has been demonstrated in patients with NP (63.6%), but
could not be demonstrated in patients with chronic
rhinosinusitis without polyps (27.3%) as compared with
control subjects. In patients with NP and comorbid
asthma or aspirin sensitivity, colonization rates were
further increased, up to 80% [15]. S. aureus has also been
detected in the submucosal space by peptide nucleic acid-
fluorescence in situ hybridization (PNA-FISH) in patients
with NP, and especially in subgroups of NP with aspirin
sensitivity [16,17].
These are both potential reservoirs for superantigen
release in the sinuses. Th2-polarized inflammation with a
resultant eosinophilic inflammatory milieu has also been
linked to the presence of S. aureus biofilms. This may occur
both dependently and independently of the superantigen
pathway, implying a direct link between microorganism
and host [18]. A different form of colonization by Staphylo-
coccus aureus, through biofilms, has received attention
recently.
A biofilm is a group of adherent bacteria irreversibly
anchored to a surface and enclosed in a matrix of
exopolysaccharide [19,20].
Fungal elements associated with bacteria within
biofilms of CRS patients have been demonstrated, an
association that could lead to enhanced virulence of
bacterial biofilms [21].
Biofilm-grown bacteria can be very resistant to fluctua-
tions in moisture, pH and temperature. They are also highly
resistant to antibiotic therapy, which may explain chronic
infections refractory to clinical management [19,20].
Foreman et al. confirmed the hypothesis that biofilms
would be present in NP patients as a nidus from which
planktonic S. aureus and superantigens are released into
the paranasal sinuses [18].
Staphylococcus aureus biofilms in NP patients have
been shown to result in eosinophilic inflammation and
significantly higher levels of IL-5 and ECP. Staphylococ-
cal superantigen-specific IgE was associated with a Th2-
skewed response and a significantly elevated total IgE,
IL-5 and ECP. The presence of Staphylococcus aureus
biofilms was also associated both with worse symptoms
and worse Lund-Mackay scores in patients with NP.
Biofilms have also been detected in control groups com-
posed of patients who underwent septoplasty surgery due
to nasal obstruction [22].
The mechanisms of this increased bacterial colonization
in NP are unclear, but recent data suggest that a defect
in the phagocytic system in NP might contribute to
increased S. aureus colonization [23].
The pathogenic impact of S. aureus in NP has been
mainly attributed to virulence factors secreted by S. aureus,
such as staphylococcal enterotoxins. However, screening
for staphylococcal superantigens genes showed no corre-
lation with the presence or severity of NP. This suggests
that the specific immune response of the host to S. aureus
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colonization, rather than the panel of enterotoxin genes
present, determines the pathophysiology of NP [24,25].
Staphylococcus aureus enterotoxins (SEs) elicit a massive
inflammatory reaction resulting in a polyclonal activation
of T and B-lymphocytes independent of the specific
adaptive immune response. Clonal expansion of the
corresponding V-β signature region of TCRs might play a
major role in the pathogenesis of NP. A significant,
specific TCR-Vβ expansion linked to the presence of
serum IgE to staphylococcal toxins was observed in NP
tissue, suggesting a superantigen reaction [26].
SEB stimulation in cultured nasal polyps increases levels
of IFN-γ and IL-4, but not of IL-10. It also upregulates
mRNA expression of T-bet and GATA-3, but not that of
Foxp3 or RORγt, which indicates that SEB is able to affect
Treg activity and cause Treg insufficiency. SEB stimulation
also increases levels of various pro-inflammatory factors,
including IL-2, IL-6, and IL-8, in cultured nasal polyps;
these, in turn, also affect Treg activity [27,28].
A second mechanism by which the local inflammatory
response can be upregulated is specific IgE directed
against S. aureus enterotoxins. IgE antibodies to S. aureus
enterotoxins were present in 28% of polyp samples, with
rates as high as 80% in the subgroup of patients with
asthma and aspirin sensitivity, as compared with 15% in
control individuals and 6% in patients with CRSsNP,
respectively [15]. The presence of specific IgE against S.
aureus enterotoxins was also coincident with higher levels
of interleukin IL-5, eotaxin and ECP. Consistent with the
increase in IL-5 and other Th2 cytokines, a significant
increase in local IgE, IgA and IgG antibodies can be
observed in polyp patients. Nasal polyp homogenates in
which S. aureus enterotoxin–IgE antibodies were detect-
able had significantly greater concentrations of IgG, IgG4
and IgE than did those without S. aureus enterotoxin-
specific IgE, positively correlating with IgE and the num-
ber of plasma cells, whereas the IgG2 fraction was signifi-
cantly lower. These changes were not reflected in the
serum of patients, confirming the notion of a local impact
of superantigens – via direct action on B cells or indirectly
via T-cell derived cytokines – on immunoglobulin synthe-
sis. S aureus superantigens can also induce the formation
of polyclonal IgE directed against multiple inhalant aller-
gens. These polyclonal IgE antibodies in NP are functional
and able to activate mast cells ex vivo upon allergen chal-
lenge; apart from typical inhalant allergens, SEB may also
serve as an allergen per se or as an indicator for superan-
tigen impact on mucosal inflammation by maintaining a
continuous activation of mast cells [29,30].
Patients with NP typically exhibit an upregulation of
proinflammatory cysteinyl leukotrienes and a downregu-
lation of prostaglandin E2, which is considered an anti-
inflammatory metabolite. NP patients who exhibit an
immune response to S. aureus have an upregulated
production of cysteinyl leukotrienes, leukotriene B4 and
lipoxin A4 as compared with tissue from nasal polyp
patients who were negative for S. aureus enterotoxin-
specific IgE [31].
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Figure 1 Illustration of the influence of Staphylococcus aureus (in orange) on the remodeling process in nasal polyposis.
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Nevertheless, a direct mechanism by which enterotoxins
can modify prostanoid metabolism and related functions
has yet to be identified.
The presence of specific IgE to staphylococcal entero-
toxins is not only associated with a more severe and
persistent inflammatory response, but is also linked to
clearly identified clinical phenotypes of NP. Rates of both
staphylococcal colonization and specific IgE to Staphylo-
coccus are increased in NP patients if co-morbid asthma
and aspirin intolerance are present [15].
Recently, the presence of IL-5 and IgE antibodies to
S. aureus enterotoxin (SE-IgE positivity) in human NP
patients was shown to be associated with an increased
risk of comorbid asthma, suggesting a decisive role of
staphylococcal superantigens in amplifying and aggrava-
ting airway disease [32].
The intersection of two paths
The dual role of TGF-ß1 – increasing the extracellular
matrix and acting as an anti-inflammatory cytokine – may
be directly involved in the development of nasal polyposis.
The lack of TGF-ß1 in nasal polyps could partially explain
the soft tissue features (edema and pseudocyst formation)
in the matrix and the severe inflammatory process found.
TGF-ß1 (and, probably, other members of the trans-
forming growth factor family as well) inhibits activation
and proliferation of helper T cells, cytotoxic T cells,
macrophages, and monocytes, and reduces the secretion
of pro-inflammatory cytokines [33,34]. It also interferes
with antibody production by B cells [35].
TGF-ß is implicated in T-cell differentiation. Treg diffe-
rentiation is favored by TGF-ß, but interleukins associated
with pro-inflammatory cytokines (such as IL-21) favor
Th17 differentiation [36].
The remodelling aspect in NP is a general pheno-
menon which is present in all subtypes of polyps (from
European subjects, Chinese subjects, SE-mediated and
non-SE-mediated polyps), but can be intensified by im-
mune response to Staphylococcus aureus superantigens.
The fibrinolytic environment found in NP is worsened
by MMP-2. MMP-9 levels have been found to increase
after Staphylococcus aureus stimulation [37].
As described above, SEs increase Th activity directly via
T-bet and GATA-3 expression, but not Treg activity
(via Foxp3), and indirectly foster a pro-inflammatory
environment, which, together with TGF-ß, can convert
Tregs into Th cells. In nasal polyps, where there is a
severely inflammatory local environment, there is an
imbalance of the Th17/Treg ratio in the blood, with an
increase in Th17 and decrease in Tregs [38].
SEs can per se lead to an increase in polyclonal IgE pro-
duction that cannot be balanced by a TGF-ß1-dependent
B-cell inhibitory effect, as it is decreased in NP. This
“flood” of polyclonal IgE fosters the acquired immune
response via dendritic cell FcεRI and Fcγ receptors and,
consequently, a Th2 response [39].
The combination of IgE overexpression and lack of
TGF-ß can enhance mast cell degranulation [40], increase
cysteinyl leukotriene production and eosinophil attraction
and, consequently, exacerbate the Th2-mediated inflam-
matory process.
The overlap of these two pathophysiologic mechanisms
clearly demonstrates that the course of nasal polyposis
can be exacerbated through the combined action of innate
(impaired remodeling of the nasal mucosa, immune
responsiveness) and acquired (environmental exposures,
such as Staphylococcus aureus) factors (Figure 1).
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